DB17017InvestigationalProtein Based Therapies
AMZ002 is a sterile injectable hormone developed as a purified synthetic polypeptide alternative to current FDA-approved epileptic seizure treatments.
- Code names
- AMZ002
What you can answer from here — as of April 23, 2025
Which companies are running trials of AMZ002, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account